Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
7 clusters · 23 sources · 30 days · First seen · Last updated
Ghana pharmaceutical and manufacturing development
Overview
Ghana is implementing strategic initiatives to bolster domestic manufacturing and reduce dependence on imported goods, with a particular focus on the healthcare sector. To address the fact that imports currently account for approximately 70% of the country’s medicine supply, with an annual import bill exceeding US$750 million, the government has launched the Ghana Pharmaceutical Manufacturing Policy (GPMP). Approved by Cabinet, this policy aims to increase the domestic market share of locally manufactured medicines from 30% to 60% within five years, moving toward a long-term goal of 70% pharmaceutical self-sufficiency. The government also intends to double pharmaceutical exports to the Economic Community of West African States (ECOWAS) markets. A central component of the GPMP is the creation of a pharmaceutical hub or park to consolidate manufacturers, research facilities, and input suppliers. Phase 2 of this plan, proposed for the Central Region, focuses on the production of active pharmaceutical ingredients (APIs), herbal medicines, and raw materials such as pharmaceutical-grade corn starch and ethyl alcohol. To support industrial growth, the Food and Drugs Authority (FDA) has introduced a new framework to guide investors. Under this pathway, investors must complete construction, equipment installation, and process validation before applying for a Good Manufacturing Practice (GMP) license. Dr. George Sabblah, Deputy CEO of the FDA, stated this aims to reduce regulatory uncertainty. Research projects are also advancing locally produced treatments through the PharmaVax Ghana initiative. The Centre for Plant Medicine Research is conducting clinical trials for URO 500, a herbal medicine for prostate health, while researchers also test the stability of a locally manufactured snake venom antiserum. Recent developments highlight the link between manufacturing and public health funding. Trade, Agribusiness and Industry Minister Elizabeth Ofosu-Adjare has emphasized the policy’s role in reducing the massive foreign exchange burden incurred by African nations for pharmaceutical imports.
Entities
Ghana · Elizabeth Ofosu-Adjare · National Vaccine Institute · Kofi Nsia-Poku · George Sabblah
Timeline
-
[HEALTH] 11 sourcesGhana and West Africa host meetings to boost vaccine manufacturing and procurement
Ghana is hosting regional meetings to strengthen the African Pooled Procurement Mechanism for vaccines and medicines, aiming to boost local manufacturing and pharmaceutical sovereignty across West Africa.
-
[HEALTH] 2 sourcesGhana develops framework to boost local pharmaceutical manufacturing
Ghana's FDA has launched a framework to support new pharmaceutical factories as the government aims to increase local medicine production from 30% to up to 70% of national needs.
-
[BUSINESS] 4 sourcesGhana launches policy to reduce medicine import reliance
Ghana has launched a new manufacturing policy to reduce its 70% reliance on imported medicines and establish a domestic pharmaceutical hub, supported by ongoing local research into herbal and venom treatments.
-
[HEALTH] 2 sourcesGhana targets local medicine production to address HIV funding gap
Ghana aims to double local medicine production to 60% within five years to reduce import reliance and address a $25.7 million annual funding gap for HIV prevention.
-
[BUSINESS] 3 sourcesWest African nations seek to boost local pharmaceutical production
Ghana and Nigeria are working to increase domestic pharmaceutical manufacturing and API production to reduce import dependency and enhance regional health security.
-
[BUSINESS] 11 sourcesGhana launches policy to boost local pharmaceutical manufacturing
Ghana has launched a new pharmaceutical manufacturing policy to double local medicine production and reduce its US$750 million annual import bill, aiming for 70% self-sufficiency.
-
[BUSINESS] 2 sourcesGhana pursues manufacturing growth through international partnerships
Ghana is seeking to strengthen domestic industrial capacity through international partnerships, including a goal to produce its first locally manufactured vaccine by 2027 via collaboration with Indonesia.
Sources
adomonline.com · agriculture.gouv.tg · burkina24.com · chale.news · echosante.info · ecofinagency.com · econoTimes.com · elitedafrique.com · ghanaguardian.com · ghananewss.com · illiconews.tg · lesoleil.sn · levisionnaire.tg · myjoyonline.com · nannews.ng · norvanreports.com · r-freenews.com · savoirnews.net · sustainabilitymea.com · theheraldghana.com · thehighstreetbusiness.com · thehighstreetjournal.com · thevaultznews.com
This summary has been updated 6 times: see revision history